OUTCOMES OF TREATMENT WITH SIROLIMUS FOR NON-INFECTIOUS UVEITIS

Lecture: Uveitis Therapeutics: Noninfectious UveitisПодробнее

Adrienne Hammill: Sirolimus Update and New Agents on the HorizonПодробнее

Quan Dong Nguyen, MD, on Sirolimus’s Potential to Change Uveitis TreatmentПодробнее

Immunosuppression for Non-Infectious Uveitis by Dr. Larissa Derzko-Dzulynsky @ COS2018Подробнее

LAM Action Patients' Meeting 2018 - Rapamycin and LAMПодробнее

Intraocular implants for Non-Infectious Uveitis by Dr. Marc de Smet @ COS2018Подробнее

Rapamycin: The Longevity Drug?Подробнее

Sirolimus shows promise for posterior segment non-infectious uveitisПодробнее

Anti-VEGF for Non-Infectious Uveitis by Dr. Amin Kherani @ COS2018Подробнее

Help Advance Treatment Options for Adults with Non-Infectious UveitisПодробнее

NON INFECTIOUS UVEITIS Dr MOHAMMED HAROONПодробнее

Rapamycin’s effect on muscle massПодробнее

Improving Outcomes in Patients With UveitisПодробнее

Exploring sirolimus as potential alternative therapy for persistent AMDПодробнее

Corticosteroids for Non-Infectious Uveitis by Dr. Chloe Gottlieb @ COS2018Подробнее

Mayo Clinic Ophthalmology Retina Update and Case Conference: Uveitis Treatment - Dr. SmithПодробнее

6cii Rapamycin TreatmentПодробнее

Use of Sirolimus in GLA/GSD/KLAПодробнее

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma - Video abstract [ID 205160]Подробнее

Panel Discussion on Non-Infectious Uveitis @ COS2018Подробнее